ArticleBMC public health2025
PERSIAN cohort biobank: creating a large-scale national resource for biomedical research in Iran.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBiobanks are essential for advancing biomedical research by providing access to high-quality biological specimens and associated data. In the Middle East, large-scale biorepositories are limited, hindering regional epidemiological and genetic studies. The PERSIAN Cohort Study Biobank was established to address this gap and support diverse research initiatives in Iran.
methodsThe Prospective Epidemiological Research Studies in Iran (PERSIAN), established in 2014, is a nationwide cohort study comprising multiple sub-cohorts. The adult cohort includes Iranian residents aged 35–70 from 18 diverse regions, capturing the country’s ethnic, environmental, and socioeconomic diversity. Upon obtaining informed consent, participants undergo standardized interviews conducted by trained personnel, completing a comprehensive 482-item questionnaire to collect detailed health and lifestyle data. Biological specimens—blood, urine, hair, and nails—are systematically collected and processed according to internationally recognised biobanking standards, ensuring sample integrity. Rigorous quality-assurance and -control checks accompany every step. The study utilizes a decentralized infrastructure with dual storage facilities to prevent sample loss, ensuring long-term preservation and accessibility. Data management is facilitated by a secure, web-based system with robust access controls, safeguarding participant confidentiality and enhancing data reliability.
resultsBy 2020, enrollment was completed at all participating centers, resulting in the collection of samples from 170,564 participants (55% female, 45% male). The cohort exhibited a diverse age distribution: 22% were aged 35–40 years, 35% were aged 41–50 years, 29% were aged 51–60 years, and 14% were over 60 years old. Geographically, over 75% of participants resided in urban areas, while 25% were from rural regions.
conclusionsThe PERSIAN Cohort Biobank now provides Iran—and the wider research community—with a rigorously curated, ethnically and geographically diverse repository of biospecimens. By integrating genetic, environmental, and socioeconomic data from a large national cohort, it establishes a new benchmark for large‑scale biobanking in resource‑limited settings and opens unprecedented opportunities for inclusive, globally relevant health research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.